Oncology Institute, Inc.·4

Sep 5, 6:12 AM ET

M33 Growth I L.P. 4

4 · Oncology Institute, Inc. · Filed Sep 5, 2025

Insider Transaction Report

Form 4
Period: 2025-09-04
Transactions
  • Sale

    Common Stock

    [F1]
    2025-09-04$3.09/sh6,018,168$18,596,1397,932,389 total
  • Sale

    Common Stock

    [F2]
    2025-09-04$3.09/sh681,832$2,106,861590,892 total(indirect: See Footnote)
Footnotes (2)
  • [F1]M33 Growth I GP LLC ("M33 LLC") is the general partner of M33 Growth I L.P. ("M33 LP") and may be deemed to beneficially own the shares held by M33 LP but disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein.
  • [F2]These securities are held by TOI M, LLC.

Documents

1 file
  • 4
    ownership.xmlPrimary